Lighthouse bolsters its US senior scientific team

Lighthouse Medical Communications US, part of the Lucid Group companies, has appointed Marc Pondel as its executive medical science director.

Pondel’s new role will see him guide the Lighthouse medical writing teams as he brings scientific and clinical strategic insight knowledge for the agency’s clients.

Andy Willmer, managing director of Lighthouse, said: “As Lighthouse expands its footprint in the USA we must ensure we build a platform of scientific capability that can continually deliver magical programmes for our clients.

“Dr Pondel brings not only a background of scientific excellence but a rich experience of creative communication approaches, which can truly impact patient outcomes.”

Pondel’s career has seen him serve in various senior-level strategic medical and advisory positions, leading teams in a number of key therapeutic areas.

He said: “The Lighthouse team is superbly capable and I look forward to helping them elevate our work in the dynamic US marketplace.

“Our shared passion for developing great medical communications programmes that help to change behaviour and improve outcomes is truly special.”